Caplight Directory>Investors>Cellex Cell Professionals GmbH>Cellex


Cellex Cell Professionals GmbH

Cellex Cell Professionals GmbH

Germanycellex.me

Overview

Cellex Cell Professionals is a Germany-based contract development and manufacturing organization (CDMO) with over 10 years of experience in autologous and allogeneic cell and gene therapy (CGT) products. The company supports partners from preclinical development through to commercialization and is involved in the manufacturing of several commercial CAR-T therapies. Its services include cell collection, supply chain management, logistics, and consulting on GMP processes. Cellex was a founding partner in the 2021 launch of AvenCell Therapeutics, a CAR T-cell therapy company, to which it contributed its switchable universal CAR-T technology and manufacturing expertise.

Portfolio Companies

1

Website

cellex.me

Investments

CompanyDateStageLead
AvenCellJun 2021Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersGermany
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.